[RGLS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
07-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 12.14%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 10,006 6,832 72 72 1,194 20,759 7,669 4.52%
PBT -15,730 -18,591 -48,647 -72,102 -81,840 -55,766 -56,679 -19.22%
Tax -467 1 62 -197 -4 -18 1 -
NP -15,263 -18,592 -48,709 -71,905 -81,836 -55,748 -56,680 -19.62%
Tax Rate - - - - - - - -
Total Cost 25,269 25,424 48,781 71,977 83,030 76,507 64,349 -14.41%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -152.54 -272.13 -67,651.39 -99,868.06 -6,853.94 -268.55 -739.08 -23.10%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -4.36 -10.77 -55.87 -114.70 -185.94 -130.12 -154.27 -44.77%
EPS Diluted -4.36 -10.77 -55.87 -114.70 -185.94 -130.12 -154.27 -44.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.